Export Ready Manufacturing Combiphar’s Padalarang facility has TGA certification enabling selected products to be exported to Australia, signaling a strong opportunity for contract manufacturing, private label partnerships, and distributor deals in the Australian market.

In-House R&D An in-house R&D facility focuses on quality optimization, bioavailability and bioequivalence, and nanotechnology, enabling collaborations on advanced formulations, generics, and nutraceuticals.

Diverse Product Portfolio With a broad range of prescription and over-the-counter products including cough syrup, eye-care, joint relief, vitamins, feminine hygiene, and hepatoprotector lines, there are cross-sell and multi-channel opportunities across pharmacies, clinics, and e-commerce.

Brand and Campaigns The company has engaged in national campaigns to promote health and walking, indicating openness to co-branding, cause-related marketing, and partnerships with media and influencers to reach mass consumer audiences.

Local Scale Advantage Being a sizable Indonesian manufacturer with a modern plant and established local distribution footprint supports competitive pricing, reliable supply to pharmacies and hospitals, and potential for private-label or exclusive distribution agreements.